Internal Medicine, Endocrinology, Diabetes, & Metabolism · Modesto, CA
NPI
1104020312
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
600 Coffee Rd
Modesto, CA, 95355
Phone (209) 524-1211
Groups this clinician bills Medicare through
Medicare paid, 2024
$505K
24,249 services
Medicare patients, 2024
950
Average age 72
Drug cost, 2024
$2.9M
7,689 prescriptions
Company payments, 2025
$62.11
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wen Han was code J0897 (injection, denosumab, 1 mg), 12,840 times for 126 patients. In total Wen Han billed 24,249 services in 11 codes, and Medicare paid $505K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 12,840 | 126 | $20.57 | $264K |
| 99214 Office E&M - Established | Office | 1,426 | 818 | $90.32 | $129K |
| 96372 Injection Administration | Office | 306 | 135 | $11.78 | $3,605 |
| 99204 Office E&M - New | Office | 196 | 196 | $121.86 | $24K |
| 83036 Blood Count | Office | 12 | 12 | $9.52 | $114 |
By year: 2022 $395K for 18,671 services; 2023 $467K for 22,203 services; 2024 $505K for 24,249 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 12 | 12 | $9.52 | $114 |
Medicare prescription drug claims, 2024
In 2024, the drug Wen Han prescribed most often to Medicare patients was Levothyroxine Sodium, with 646 prescriptions and refills. In total Wen Han wrote 7,689 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 646 | 1,639 | 162 | $6,492 |
| Jardiance Empagliflozin | 524 | 792 | 106 | $452K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 371 | 822 | 110 | $60K |
| Ozempic Semaglutide | 325 | 543 | 69 | $496K |
| Alendronate Sodium Generic | 322 | 628 | 80 | $2,297 |
| Atorvastatin Calcium Generic | 303 | 796 | 83 | $2,314 |
| Glipizide Er Glipizide | 297 | 653 | 72 | $3,159 |
| Metformin Hcl Generic | 294 | 823 | 92 | $2,882 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 263 | 613 | 97 | $22K |
| Humalog Kwikpen U-100 Insulin Lispro | 261 | 516 | 77 | $69K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 241 | 597 | 67 | $198K |
| Metformin Hcl Er Metformin Hcl | 209 | 546 | 61 | $2,156 |
| Mounjaro Tirzepatide | 204 | 213 | 45 | $215K |
| Trulicity Dulaglutide | 184 | 279 | 43 | $274K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 173 | 407 | 64 | $15K |
Brand drugs: 3,832 claims; generic drugs: 2,954 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wen Han $62.11 ($62.11 in general payments such as food, travel and fees) from 2 companies. The largest payer was Dexcom, Inc. with $38.53.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.